The Motley Fool Podcasts Industry Focus Healthcare: Who Had the Better Quarter, Gilead Sciences or Amgen?

Healthcare: Who Had the Better Quarter, Gilead Sciences or Amgen? Logo

Healthcare: Who Had the Better Quarter, Gilead Sciences or Amgen?

It's a battle of the big bio's on this episode of Industry Focus Healthcare. Is Gilead Sciences finally overcoming its hep C headwind? Is Amgen beating back biosimilars? We dig into the details as we discuss which of these biopharma behemoths delivered better first quarter results. Stocks: GILD, AMGN

Check out more of our content here:

Listen to Healthcare: Who Had the Better Quarter, Gilead Sciences or Amgen?

Recent Episodes

Listen
Listen
Listen
Listen
Listen
Listen
Listen
Listen
Listen
Listen

More Podcasts